US FDA Grants Orphan Drug Designation of SN Bioscience's Nano Anti-Cancer Drug 'SNB-101' for Small Cell Lung Cancer

/PRNewswire/ -- SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on July 19 that the US FDA had granted an orphan drug designation for small cell lung...

Related Keywords

Gyeonggi Do ,Kyonggi Do ,South Korea ,Pangyo ,Seongnam , ,Sn Bioscience Inc ,Prnewswire Sn Bioscience Co ,Pangyo Techno Valley ,